baber/WOPTO huggingface dataset:
Patent BR-PI0915632-B1 (BR)
Title: processo de fabricação de uma pá de estator, pá de estator construída em um material compósito e turbomáquina.
Inventor: JEAN NOËL MAHIEU
IPC: B29B11/16
Filed: 2009-07-09
Abstract: "processo de fabricação de uma pá de estator, pá de estator construída em um material compósito e turbomáquina" a invenção se refere a um processo de fabricação de uma pá de estator. esse processo compreende a elaboração por tecelagem 3d em uma só peça de uma pré-forma fibrosa (1) que compreende uma primeira parte (10) que se estende de acon:lo com um eixo longitudinal (a) e que constitui a pré-forma da lâmina da dita pá, e, em l_jma extremidade longitudinal (11) da dita primeira parte (10), uma segunda parte (20) que constitui a pré-forma da plataforma da dita pá, a segunda parte (20) sendo elaborada em uma primeira camada (40) e uma segunda camada (50) em frente à primeira camada e separada da dita primeira camada ( 40) por desunião sem corte por ocasião da elaboração da dita pré-forma (1), a dobragem da primeira camada (40) e da segunda camada (50) de tal modo que cada uma esteja em um plano perpendicular ao dito eixo longitudinal substancialmente simetricamente uma da outra em relação à dita primeira parte (10), e que uma região (r1) da primeira camada ( 40) recubra uma segunda região (r2) da segunda camada (50) na frente de uma borda dianteira (15) da dita primeira parte, a conformação da dita pré-forma (1) dentro de um molde, e a densificação da dita pré-forma ( 1) com uma matriz polimérica.
Patent EA-001382-B1 (EA)
Title: Process for the production of powdered pulmonry surfactant preparations
Inventor: EISTETTER KLAUS
IPC: A61K35/42
Filed: 1997-01-18
Abstract: 1. A process for producing a powered pulverulent pulmonary surfactant preparation containing hydrophobic pulmonary surfactant proteins, which comprises subjecting an organic solution or suspension containing hydrophobic pulmonary surfactant proteins and, if desired, further components to spray drying. 2. The process as claimed in claim 1, wherein the hydrophobic pulmonary surfactant proteins present in the organic solution or suspension are SP-C and/or SP-B. 3. The process as claimed in claim 2, wherein SP-C is present in the organic solution or suspension. 4. The process as claimed in claim 1, wherein the organic solution or suspension contains from 5 to 15% by weight of water. 5. The process as claimed in claim 1, wherein the further components are phospholipids. 6. The process as claimed in claim 1, wherein the spray drying is carried out in a heated gas. 7. The process as claimed in claim 6, wherein the gas used is air or nitrogen. 8. The process as claimed in claim 6, wherein the gas has an inlet temperature of from 60 to 200 degree C and an outlet temperature of from 40 to 80 degree C. 9. The process as claimed in claim 7, wherein the gas has an inlet temperature of from 90 to 150 degree C and an outlet temperature of from 50 to 70 degree C. 10. A powered pulverulent pulmonary surfactant preparation obtained by processes as claimed in claims 1 to 9.
Patent EA-004769-B1 (EA)
Title: Novel pharmaceutical
Inventor: BLACKLER PAUL DAVID JAMES
IPC: A61K31/00
Filed: 2000-04-19
Abstract: 1. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, hydrochloride monohydrate in crystalline form characterised in that it: (i) provides an infrared spectrum containing peaks at 3358, 2764, 1245, 833 and 760 cm<-1>; and/or (ii) provides an X-ray powder diffraction (XRPD) pattern containing peaks at 15.0; 17.7; 23.0; 30.0 and 31.4 degree 2theta. 2. A hydrate according to claim 1, which provides an infra red spectrum substantially in accordance with Figure I. 3. A hydrate according to claim 1 or claim 2, which provides an X-ray powder diffraction (XRPD) pattern substantially in accordance with Figure II. 4. A hydrate according to any one of claims 1 to 3, in isolated form. 5. A hydrate according to any one of claims 1 to 4, in pure form. 6. A process for preparing a hydrate according to claim 1, characterised in that [4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (Compound I) is treated with a suitable source of hydrochloride counter-ion and an appropriate amount of water for formation of the Hydrochloride Hydrate; and thereafter the required compound is recovered. 7 A pharmaceutical composition comprising an effective, non-toxic amount of a hydrate according to claim 1 and a pharmaceutically acceptable carrier therefor. 8. A hydrate according to claim 1, for use as an active therapeutic substance. 9. A hydrate according to claim 1, for use in the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof. 10. The use of hydrate for the manufacture of a medicament for the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof. 11. A method for the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof, in a human or non-human mammal which comprises administering an effective, non-toxic, amount of hydrate to a human or non-human mammal in need thereof.
Patent EA-003884-B1 (EA)
Title: Vig-1 propulsive unit
Inventor: GOLUBEV VLADIMIR IOSIFOVICH
IPC: B64C33/02
Filed: 2001-04-02
Abstract: 1. The inventive propulsive unit as at least on wing connected, with the aid of a root thereof, to a driving element, which performs a swinging and spherical motion by means of a crank-type joint fitted with a inclined crank and mounted on a base of a driving shaft, and also by means of a supporting kinematic chain which links the driving element to the base, characterized in that the supporting kinematic chain is embodied, at least in the form of two links e.g. a guide strip and an associated with it slipper one link being connected to a driven element, and the second link being connected to the base. 2. The inventive propulsive unit, according to claim 1, characterized in that the guide strip is disposed on driving element in plane, passing through the axis of inclined crank, and the slipper is disposed on the base. 3. The inventive propulsive unit, according to claim 1, characterized in that the guide strip is disposed on the plane base, passing through the axis of driving shaft, and the and the slipper is disposed on driving element. 4. The inventive propulsive unit, according to claims 1, 2, 3, characterized in that the guide strips are disposed on driving element and on the base, and associated with them slippers are disposed accordingly on the base and on driving element in perpendicular planes. 5. The inventive propulsive unit, according to claims 1, characterized in that the base is provided with tubular part, and driving shaft is made with inclined cranks on the ends, connected, accordingly, with two joints with driving element, driving shaft being provided with installed in its middle part gear conic wheel interacting with bevel pinion, installed on the shaft, passing inside of tubular part of the base. 6. The inventive propulsive unit, according to claims 5, characterized in that the driving element is combined with the casing and encompassing the working shaft fitted with a gear wheel and a bevel pinion, and the casing is provided with skirt encompassing a tubular part of the base, the guide strip being disposed in the skirt, and the associated slipper is made in form of a cylinder installed on the tubular part of the base. 7. The inventive propulsive unit, according to claims 6, characterized in that the cylinder is provided with pneumatic tyre. 8. The inventive propulsive unit, according to claims 6, characterized in that the casing is provided with at least one console, perpendicular to the axis of inclined cranks, and the end of console is connected by traction with the front edge of the wing.
Patent EA-013842-B1 (EA)
Title: Process for the preparation of intermediates
Inventor: WANG LINHUA
IPC: C07C17/093
Filed: 2006-02-07
Abstract: The present invention provides a process for the production of intermediate compounds of formula (I),wherein the substituents R, R, R, and Rare as defined herein and X is chloro or bromo. The process comprises reacting a substituted aniline with aqueous HX, followed by removal of water by azeotropic distillation and diazotization and pyrolysis with an organic nitrite at elevated temperatures in the absence of a copper catalyst. Alternatively, gaseous HX can be used to substitute aqueous HX in the process. Consequently, a step of water removal by azeotropic distillation can be eliminated. The intermediate compounds of formula I are suitable as intermediates in the preparation of herbicidally active 3-hydroxy-4-aryl-5- oxopyrazoline derivatives.
Patent EA-013973-B1 (EA)
Title: Methods for treating cutaneous lupus using aminoisoindoline compounds
Inventor: ZELDIS JEROME B
IPC: A61K31/4035
Filed: 2006-12-28
Abstract: Methods of treating cutaneous lupus in a human are disclosed. Specific methods encompass the administration of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione (ACTIMID), 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione (REVLIMID®), or cyclopropyl 2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindolin-4-yl} carboxamide, alone or alternatively, in combination with a second active agent.
Patent EA-016323-B1 (EA)
Title: Derivatives of sulindac, use thereof and preparation thereof
Inventor: PIAZZA GARY
IPC: A61K31/74
Filed: 2007-01-04
Abstract: Derivatives of sulindac are provided along with-pharmaceutical compositions containing them and use for precancerous conditions and treating cancer. Derivatives of sulindac are also suitable for treating chronic inflammatory conditions. A method for preparing the derivatives is also provided.
Patent EA-012277-B1 (EA)
Title: Process for purification of oil and/or oil-contaminated soil, cuttings, oil-slimes or refused drilling fluid
Inventor: BATURBAEV EDUARD MAUKENOVICH
IPC: B09C1/00
Filed: 2009-01-12
Abstract: The invention relates to oil pollution elimination, formed to oil or oil products pouring on soil and can be used for soil reclamation, processing of oil-slimes and refused drilling fluids for separation of oil and oil products therefrom.The invention is aimed at a method simplification, improvement of labor productivity, lesser power consumption and providing to produce a target product and characterized in that the method of processing oil-polluted soils, drilling cuttings, oil-slimes or refused comprising separation of feed product into flowing and precipitating phases in a tank and washing out the separated phases, the precipitating phase is mixed and transported by a screw conveyor and further separate into solid and liquid fractions in a decanter by a centrifugal force, wherein the flowing phase is cleaned from mechanical pollutants and desalinated to obtain tank oil and/or oil products.A container is placed in the tank to collect large mechanical impurities.The solid fraction from the decanter is burnt in a furnace or subjected to a biological treatment.When separating, the feed material is heated to 90°C.The flowing phase is cleaned from mechanical impurities in a settling tank separated by a partition and a barrier for settling impurities before the barrier and discharging the purified product via an overflow formed between the partition and the barrier.After the desalination the tank oil and/or oil products are subjected to centrifugal decantation for an additional impurities removal.Prior to the desalination, steam is supplied tangentially to the purified product.
Patent EA-017832-B1 (EA)
Title: Granule and orally disintegrating tablet comprising oxycodone
Inventor: HOARAU DIDIER
IPC: A61K9/00
Filed: 2007-07-31
Abstract: The present invention relates to granules comprising oxycodone, as well as to orally disintegrating tablets including same and optionally acetaminophen d also to a process for manufacturing tablets and use tablets or granules and method for providing a medicament for reducing pain in a patient, comprising oral administration thereof.
Patent EA-016992-B1 (EA)
Title: Cabin of construction site hoist
Inventor: CHERNOV NIKOLAJ GRIGORIEVICH
IPC: B66B11/02
Filed: 2010-04-05
Abstract: The invention relates to hoisting transport arrangements, in particular to construction pillar lifts comprising a cabin with two doors. The invention is aimed at improving reliability of the cabin design, the cabin comprises a door and a landing ladder hinged connected and ropes 18. The door includes a frame 1 and a leaf 2 with a handle. The landing ladder 3 has side railing 4. The ropes 18 connecting the door with the landing ladder are arranged inside poles 11 of the side railing 4 of the landing ladder 3. A threshold 8 of the landing ladder 3 has a recess 9 at side ends. Holders 17 are provided on lateral sides of the door frame 1 adapted to cooperate with said recesses 9.
Patent EA-023154-B1 (EA)
Title: Process for the preparation of a solid metallocene catalyst system and its use in polymerisation of olefins
Inventor: VALONEN JENNI
IPC: C08G65/00
Filed: 2011-04-28
Abstract: A process for the preparation of a solid olefin polymerisation catalyst system, comprising an organometallic compound of a transition metal of Group 3 to 10 of the Periodic Table (IUPAC 2007) in the form of solid particles comprising the steps of I) generating an emulsion by dispersing a liquid clathrate in a solvent (S) wherein (i) the solvent (S) constitutes the continuous phase of the emulsion and comprises a nonreactive fluorinated synthetic oil having a viscosity at 20°C according to ASTM D445 of at least 10 up to 2000 cSt; (ii) the liquid clathrate constitutes in form of droplets the dispersed phase of the emulsion, II) solidifying said dispersed phase to convert said droplets to solid particles, and III) optionally recovering said particles to obtain said catalyst system, wherein the liquid clathrate comprises (a) a lattice being the reaction product of a) a transition metal compound of formula (I) LRTX(I), wherein T is a transition metal of anyone of the groups 3 to 10 of the Periodic Table (IUPAC 2007), preferably a transition metal of anyone of the groups 4 to 6 of the Periodic Table (IUPAC 2007), more preferably titanium (Ti), zirconium (Zr) or hafnium (Hf), i.e. zirconium (Zr) or hafnium (Hf), each X is independently a monovalent σ-ligand, each L is independently an organic ligand which coordinates to the transition metal (T), R is a bridging group linking said organic ligands (L), m is 2 or 3, preferably 2, n is 0, 1 or 2, preferably 1, q is 1, 2 or 3, preferably 2, m+q is equal to the valency of the transition metal (T), a) a cocatalyst comprising aluminoxane, a) a compound being effective to form the lattice with the transition metal compound and/or the aluminoxane, and b) a hydrocarbon solvent (HS).
Patent EA-023443-B1 (EA)
Title: Vortex finder support and cyclone
Inventor: WERCHOWSKI OLENA
IPC: B04C5/13
Filed: 2011-01-11
Abstract: This invention relates to a vortex finder support for fixing a vortex finder (4) in the inlet region (2) of a cyclone (1). For this purpose a ring (5) is provided, which surrounds a waste gas conduit (3) leading out of the inlet region (2) of the cyclone (1). Through openings (5c) in the ring (5) bolts (7) can be passed into the vortex finder (4) or into a support element (6) connectable with the same.
Patent EA-022523-B1 (EA)
Title: Method for treating laundry using ozone in a washing machine at low temperature and washing machine suitable for said method
Inventor: EGLMEIER HANS
IPC: D06F58/20
Filed: 2011-05-31
Abstract: The invention relates to a method for treating laundry (7) using ozone in a washing machine, which comprises a suds container (1), a drum (2) rotatably supported in the suds container (1) for accommodating the laundry (7) to be treated with ozone, and a device (20) for providing ozone, wherein ozone-containing air at a temperature of no more than 35°C is introduced into the drum (2) onto washed laundry (7) that is in the drum (2) and that is still damp, while substantially no detergents or washing additives are in the drum (2), and wherein subsequently a rinsing process is carried out for the laundry (7) in the drum (2). The invention further relates to a washing machine that is especially suitable for said method.
Patent EA-025147-B1 (EA)
Title: Security element and method for producing same
Inventor: DEGOTT PIERRE
IPC: B42D15/00
Filed: 2012-02-03
Abstract: Disclosed is a device for the counterfeit protection of a banknote, a document of value or an article. The device comprises a substrate (S), and on said substrate (S) a plurality of jointly visible zones of first (1) and of second (2) hardened coatings comprising magnetically oriented pigment particles (P1, P2) in a transparent binder (M1, M2), said first (1) hardened coating having a pigment orientation imitating a first curved surface and said second (2) hardened coating having a pigment orientation imitating a second curved surface different from said first curved surface. The device is characterized in that, along a linear section through the device, at least one zone of said second (2) hardened coating is contiguously located between two zones of said first (1) hardened coating. The coatings can be aside each other, on top of each other, and/or on both sides of a transparent substrate so as to form a see -through feature. Disclosed are further a method for producing said device, the use of said device, as well as security documents carrying said device. The method also comprises consecutive selective hardening steps alternating with orienting steps.
Patent EA-022850-B1 (EA)
Title: Piperidinone carboxamide azaindane cgrp receptor antagonists
Inventor: BELL IAN M
IPC: A61K31/437
Filed: 2011-11-10
Abstract: The present invention is directed to piperidinone carboxamide azaindane derivatives of formula I which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
Patent EA-022470-B1 (EA)
Title: C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
Inventor: REGUEIRO-REN ALICIA
IPC: C07J63/00
Filed: 2012-01-27
Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, C-17 and C-3 modified triterpenoids that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formulas I, II and III:These compounds are useful for the treatment of HIV and AIDS.
Patent EA-025100-B1 (EA)
Title: Cycloalkyl-fused tetrahydroquinolines as crthreceptor modulators
Inventor: HUANG XIANHAI
IPC: C07D215/00
Filed: 2012-06-14
Abstract: The invention provides certain cycloalkyl-fused tetrahydroquinolines of the Formula (I), and their pharmaceutically acceptable salts and esters, wherein R, R, R, R, R, E, Y, Z, n, u, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTHfunction.
Patent EA-030482-B1 (EA)
Title: Combination of direct acting antiviral agents and ribavirin for treating hcv patients
Inventor: BERNSTEIN BARRY M
IPC: A61P31/22
Filed: 2014-03-14
Abstract: The present invention relates to a method for the treatment of hepatitis C virus (HCV), comprising administering two direct acting antiviral agents (DAAs) and ribavirin to an HCV patient, wherein said treatment does not include administration of interferon to said patient, and said treatment lasts for 12 weeks, and wherein said two DAAs comprise a Compound 1or a pharmaceutically acceptable salt thereof, and a Compound 2or a pharmaceutically acceptable salt thereof.
Patent EA-030406-B1 (EA)
Title: Parallel-flux optical cell based on light-emitting diodes of 1600–5000 nm spectral range
Inventor: VELIKOTNY MIKHAIL ALEXANDROVICH
IPC: G01N21/3504
Filed: 2015-12-18
Abstract: The invention generally is related to devices for determination of gases in a medium under analysis, in particular, to optical cells based on LEDs of 1600-5000 nm spectral range for chemical substances sensors. The invention proposes a device for determination of gases in a medium under analysis comprising a casing that houses at least one LED emitter, a gas cell, a photodiode, an electronic unit, a first and a second spherical mirrors, wherein the casing has openings for gas medium under analysis entering the gas cell, at least one LED emitter is able to provide radiation in a spectral range of 1600-5000 nm, the gas cell is disposed so that emission of at least one LED emitter passes through it, the photodiode is disposed so as to receive emission of at least one LED emitter, the electronic unit is able to control of at least one LED emitter and includes a photodiode preamplifier board, the first spherical mirror is located in front of the gas cell to create a parallel emission beam from at least one LED emitter toward the gas cell, the second spherical mirror is located behind the gas cell to collect the emission that passed through the gas cell and to direct it to the photodiode, at least one LED emitter and/or photodiode being mounted on sapphire glass.
Patent EA-034531-B1 (EA)
Title: Composition comprising pediococcus pentosaceus bacteria inducing the production of il-10 by thp-1 macrophages
Inventor: CUNE CASTELLANA JORDI
IPC: C12N1/20
Filed: 2014-08-07
Abstract: The invention provides a bacterial composition to reduce inflammation in the intestinal tract comprising from 10to 10cfu/g of Pediococcus pentosaceus viable cells which have the ability to induce the production of inteheukin-10 by THP-1 macrophages. The invention also provides the use of said bacterial composition in the amelioration of excessive crying in infants.
Patent EA-031120-B1 (EA)
Title: Selective control of groups of detonators
Inventor: SCHLENTER CRAIG CHARLES
IPC: F42D1/055
Filed: 2014-08-26
Abstract: A method of communicating with a detonator assembly wherein an encryption key associated with the detonator assembly is stored in the detonator assembly and a message, intended for the detonator assembly, is encrypted at the control location using the encryption key whereupon the encrypted message is transmitted to each of a plurality of detonator assemblies and each received message is decrypted and validated.
Patent EA-031603-B1 (EA)
Title: Production of olefins from a methane conversion process
Inventor: NICHOLAS CHRISTOPHER P
IPC: C07C5/09
Filed: 2014-09-03
Abstract: The invention proposes a method for producing olefins wherein fuel and oxygen are combusted to produce a hot carrier fluid; a hydrocarbon feed stream including methane is introduced into a supersonic reactor; said carrier fluid is mixed with said hydrocarbon feed stream in the mixing zone; methane pyrolysis is performed in the supersonic reactor to form a reactor effluent stream comprising acetylene as a first process stream; the reactor effluent stream is passed to a first hydrocarbon conversion zone to form a second process stream comprising a second hydrocarbon compound; and the second process stream is passed to a second hydrocarbon conversion zone to form a third process stream comprising Cto Colefins; wherein the first hydrocarbon conversion zone comprises a hydroprocessing zone, and the second hydrocarbon conversion zone comprises an olefin conversion zone.